Reva Agri Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-12-2024
- Paid Up Capital ₹ 1.36 M
as on 10-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.76 Cr
as on 10-12-2024
- Revenue -30.58%
(FY 2016)
- Profit 126.36%
(FY 2016)
- Ebitda 153.05%
(FY 2016)
- Net Worth 9.20%
(FY 2016)
- Total Assets 2.15%
(FY 2016)
About Reva Agri Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.36 M.
The company has closed loans amounting to ₹3.76 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nanalal Shah, Vijaysinh Suratia, Vallabhbhai Zadafia, and Three other members serve as directors at the Company.
- CIN/LLPIN
U01110GJ2007PTC050479
- Company No.
050479
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Reva Agri Biotech?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaysinh Suratia  | Director | 10-Apr-2007 | Current |
| Nanalal Shah | Director | 10-Apr-2007 | Current |
| Vallabhbhai Zadafia | Director | 10-Apr-2007 | Current |
| Vikramsinh Parmar | Director | 10-Apr-2007 | Current |
| Dhirubhai Sawani | Director | 10-Apr-2007 | Current |
| Ghanshyambhai Patel | Director | 30-Mar-2019 | Current |
Financial Performance of Reva Agri Biotech.
Reva Agri Biotech Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 30.58% decrease. The company also saw a substantial improvement in profitability, with a 126.36% increase in profit. The company's net worth moved up by a moderate rise of 9.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reva Agri Biotech?
In 2017, Reva Agri Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Action For Education FoundationActive 10 years 10 monthsVijaysinh Suratia and Vallabhbhai Zadafia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Ltd Creation Date: 30 Oct 2010 | ₹1.48 Cr | Satisfied |
Axis Bank Ltd Creation Date: 20 Mar 2010 | ₹1.48 Cr | Satisfied |
State Bank Of India Creation Date: 25 Apr 2008 | ₹8.00 M | Satisfied |
How Many Employees Work at Reva Agri Biotech?
Unlock and access historical data on people associated with Reva Agri Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reva Agri Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reva Agri Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
